These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19189321)

  • 41. Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival.
    Motyl KJ; McCauley LK; McCabe LR
    J Cell Physiol; 2012 Apr; 227(4):1326-34. PubMed ID: 21604269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats.
    Wang L; Orhii PB; Banu J; Kalu DN
    Bone; 2001 Feb; 28(2):202-7. PubMed ID: 11182379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1.
    Bodine PV; Seestaller-Wehr L; Kharode YP; Bex FJ; Komm BS
    J Cell Physiol; 2007 Feb; 210(2):352-7. PubMed ID: 17044082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice.
    Bouxsein ML; Pierroz DD; Glatt V; Goddard DS; Cavat F; Rizzoli R; Ferrari SL
    J Bone Miner Res; 2005 Apr; 20(4):635-43. PubMed ID: 15765183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The calcium-sensing receptor mediates bone turnover induced by dietary calcium and parathyroid hormone in neonates.
    Shu L; Ji J; Zhu Q; Cao G; Karaplis A; Pollak MR; Brown E; Goltzman D; Miao D
    J Bone Miner Res; 2011 May; 26(5):1057-71. PubMed ID: 21542007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intermittent parathyroid hormone (PTH) treatment and age-dependent effects on rat cancellous bone and mineral metabolism.
    Friedl G; Turner RT; Evans GL; Dobnig H
    J Orthop Res; 2007 Nov; 25(11):1454-64. PubMed ID: 17557320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2.
    Ferrari SL; Pierroz DD; Glatt V; Goddard DS; Bianchi EN; Lin FT; Manen D; Bouxsein ML
    Endocrinology; 2005 Apr; 146(4):1854-62. PubMed ID: 15705780
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation.
    Morinobu M; Nakamoto T; Hino K; Tsuji K; Shen ZJ; Nakashima K; Nifuji A; Yamamoto H; Hirai H; Noda M
    J Exp Med; 2005 Mar; 201(6):961-70. PubMed ID: 15781586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
    Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP
    J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
    von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
    J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BMP signaling is required for adult skeletal homeostasis and mediates bone anabolic action of parathyroid hormone.
    Khan MP; Khan K; Yadav PS; Singh AK; Nag A; Prasahar P; Mittal M; China SP; Tewari MC; Nagar GK; Tewari D; Trivedi AK; Sanyal S; Bandyopadhyay A; Chattopadhyay N
    Bone; 2016 Nov; 92():132-144. PubMed ID: 27567726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone.
    Yakar S; Bouxsein ML; Canalis E; Sun H; Glatt V; Gundberg C; Cohen P; Hwang D; Boisclair Y; Leroith D; Rosen CJ
    J Endocrinol; 2006 May; 189(2):289-99. PubMed ID: 16648296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
    Yamane H; Sakai A; Mori T; Tanaka S; Moridera K; Nakamura T
    Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).
    Wang L; Quarles LD; Spurney RF
    J Bone Miner Res; 2004 Oct; 19(10):1661-70. PubMed ID: 15355561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disruption of the aldehyde dehydrogenase 2 gene increases the bone anabolic response to intermittent PTH treatment in an ovariectomized mouse model.
    Kosugi K; Tajima T; Menuki K; Okuma KF; Tokuda K; Fukuda H; Okada Y; Tsukamoto M; Yamanaka Y; Zenke Y; Sakai A
    Bone; 2020 Jul; 136():115370. PubMed ID: 32325250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of combination therapy with PTH and 17beta-estradiol on long bones of female mice.
    Samuels A; Perry MJ; Gibson R; Tobias JH
    Calcif Tissue Int; 2001 Sep; 69(3):164-70. PubMed ID: 11683531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration.
    Jilka RL; Almeida M; Ambrogini E; Han L; Roberson PK; Weinstein RS; Manolagas SC
    Aging Cell; 2010 Oct; 9(5):851-67. PubMed ID: 20698835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Skeletal recovery after weaning does not require PTHrP.
    Kirby BJ; Ardeshirpour L; Woodrow JP; Wysolmerski JJ; Sims NA; Karaplis AC; Kovacs CS
    J Bone Miner Res; 2011 Jun; 26(6):1242-51. PubMed ID: 21308774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of the nuclear matrix in the control of skeletal genes: the NMP1 (YY1), NMP2 (Cbfa1), and NMP4 (Nmp4/CIZ) transcription factors.
    Bidwell JP; Torrungruang K; Alvarez M; Rhodes SJ; Shah R; Jones DR; Charoonpatrapong K; Hock JM; Watt AJ
    Crit Rev Eukaryot Gene Expr; 2001; 11(4):279-97. PubMed ID: 12067068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Negative regulation of bone morphogenetic protein/Smad signaling by Cas-interacting zinc finger protein in osteoblasts.
    Shen ZJ; Nakamoto T; Tsuji K; Nifuji A; Miyazono K; Komori T; Hirai H; Noda M
    J Biol Chem; 2002 Aug; 277(33):29840-6. PubMed ID: 12023967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.